1 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132.
|
2 |
Gingold JA, Zhu D, Lee DF, et al. Genomic profiling and metabolic homeostasis in primary liver cancers[J]. Trends Mol Med, 2018,24(4):395-411.
|
3 |
Abdelaziz AO, Shousha HI. Survival and prognostic factors for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience[J]. Asian Pac J Cancer, 2014, 15(9):3915-3920.
|
4 |
Dalton-Fitzgerald E, Tiro J. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis[J]. Clin Gastroentero Hepatol, 2014,13(4):1542-3565.
|
5 |
Hung CH, Hu TH, Lu SN, et al. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus[J]. Int J Cancer, 2016,138(3):714-720.
|
6 |
Zhang Z, Zhang Y, Wang Y, et al. Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma[J]. Onco Targets Ther, 2016,9:123-129.
|
7 |
Thurnherr T, Mah WC, Lei Z, et al. Differentially expressed MicroRNAs in hepatocellular carcinoma target genes in the genetic information processing and metabolism pathways[J]. Sci Rep, 2016,6:20065.
|
8 |
Guindon-Kezis KA, Mulder JE, Massey TE. In vivo treatment with aflatoxin B1 increases DNA oxidation, base excision repair activity and 8-oxoguanine DNA glycosylase 1 levels in mouse lung[J]. Toxicology, 2014,321:21-26.
|
9 |
Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways[J]. Cancer Cell, 2016,29:452-463.
|
10 |
Hauptman N, Glavac D. MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer[J]. Radiol Oncol, 2013,47(4):311-318.
|
11 |
Amaral PP, Leonardi T, Han N, et al. Genomic positional conservation identifies topological anchor point RNAs linked to developmental loci[J]. Genome Biol, 2018,19(1):32.
|
12 |
Sun CC, Zhang L, Li G, et al. The lncRNA PDIA3P interacts with miR-185-5p to modulate oral squamous cell carcinoma progression by targeting cyclin D2[J]. Mol Ther Nucleic Acids, 2017,9:100-110.
|
13 |
Ji J, Tang J, Deng L, et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway[J]. Oncotarget, 2015,6(40):42813-42824.
|
14 |
Huang MD, Chen WM, Qi FZ, et al. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2[J]. Mol Cancer, 2015,14(8):165-174.
|
15 |
Tao R, Hu S, Wang S, et al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma[J]. Carcinogenesis, 2015,36(10):1136-1143.
|
16 |
Hu L, Ye H, Huang G, et al. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21[J]. Tumour Biol, 2016,37(2):2691-2702.
|
17 |
Sheng L, Wu J, Gong X, et al. SP1-induced upregulation of lncRNA PANDAR predicts adverse phenotypes in retinoblastoma and regulates cell growth and apoptosis in vitro and in vivo[J]. Gene, 2018,668:140-145.
|
18 |
Liu J, Ben Q, Lu E, et al. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer[J]. Cell Death Dis, 2018,9(2):168.
|
19 |
Peng W, Fan H. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma[J]. Biomed Pharmacother, 2015,72:113-118.
|
20 |
Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma[J]. Clin Cancer Res, 2006,12:4851-4858.
|
21 |
El-Tawdi AH, Matboli M, El-Nakeep S, et al. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma[J]. Expert Rev Gastroenterol Hepatol, 2016,10(7):869-877.
|
22 |
Huppi K, Pitt JJ, Wahlberg BM, et al. The 8q24 gene desert: an oasis of non-coding transcriptional activity[J]. Front Genet, 2012,3:69.
|
23 |
Zhang Y, Dang YW, Wang X, et al. Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics[J]. Am J Transl Res, 2017,9(9):3904-3917.
|
24 |
Gao JZ, Li J, Du JL, et al. Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence[J]. Oncol Lett, 2016,11:1791-1798.
|
25 |
Fujisaka Y, Iwata T, Tamai K, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines[J]. Oncol Lett, 2018,15:509-514.
|
26 |
Wu Y, Lyu H, Liu H, et al. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer[J]. Sci Rep, 2016, 6:31093.
|
27 |
Wang Y, Jing W, Ma W, et al. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma[J]. Cancer Biomark, 2018, 22(2):227-236.
|
28 |
França GS, Vibranovski MD, Galante PA. Host gene constraints and genomic context impact the expression and evolution of human microRNAs[J]. Nat Commun, 2016,7:11438.
|
29 |
Dong Y, Yan W, Zhang SL, et al. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy[J]. Oncotarget, 2017,8(69):114041-114049.
|
30 |
Wu Y, Huang C, Meng X, et al. Long noncoding RNA MALAT1: insights into its biogenesis and implications in human disease[J]. Curr Pharm Des, 2015,21(34):5017-5028.
|
31 |
Sonohara F, Inokawa Y, Hayashi M, et al. Prognostic value of long non-coding RNA HULC and MALAT1 following the curative resection of hepatocellular carcinoma[J]. Sci Rep, 2017,7(1):16142.
|
32 |
Chen SX, Yin JF, Lin BC, et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC[J]. Tumour Biol, 2016,37(5):6801-6812.
|
33 |
Zhang JH, Wei HW, Yang HG. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2016, 20(9):1720-1724.
|